Aiding Regulatory Submissions Through Robust Bioanalytical Studies
A thorough understanding of both regulatory requirements and study challenges can help develop and validate the appropriate methods for a bioanalytical study program.
Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
Avance Clinical Acquires C3 Research Associates
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.
ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center
In partnership with the University of Pittsburgh, ElevateBio will open its next manufacturing center in the city.
Lonza and Touchlight Enter mRNA Collaboration
Touchlight will expand Lonza’s end-to-end offering for mRNA manufacturing with an additional, differentiated source of DNA raw material.
Bio-Rad Launches Anti-Evolocumab Antibodies
Bio-Rad’s new antibodies are designed to develop highly selective pharmacokinetic (PK) and anti-drug antibody (ADA) assays for evolocumab and its biosimilars.
Roche Launches Digital PCR System
Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.
NIH-Funded Scientists Develop Mouse Embryo Model That Generates Neural Tubes
Scientists have developed a mouse model that could be a promising model system for research into factors affecting mammalian embryonic development and disease.
Validair Diamond Scientific Installs New Cleanroom
Validair Diamond Scientific has installed a new cleanroom for in-house testing, research, and training.
CYTENA Unveils Fully Automated Single-Cell Dispenser for Microorganisms
CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.
New England Biolabs Releases Novel Enzymatic mRNA Capping Solution
The Faustovirus Capping Enzyme launched by New England Biolabs is designed to increase capping efficiency and scalability of mRNA manufacturing workflows.
